Genome Based Diagnostics has announced the launch of its proprietary Liquid Biopsy Kits, designed to aid in the early detection of certain cancers. The kits are expected to roll out later this quarter, representing a significant step in non-invasive cancer diagnosis.
Founded by Dr. Thomas Crisman, Genome Based Diagnostics has focused on developing accessible and reliable testing solutions that leverage advanced DNA/RNA extraction technology. The company's liquid biopsy kits use first void urine, blood and oral swabs, offering a convenient alternative to traditional biopsy procedures offering a less invasive approach to provide rich genetic analysis.
